Network pharmacology prediction of UA in targeting endometriosis progression to endometrial cancer.
Endometriosis is a gynecological disorder predominantly affecting women of reproductive age and is considered a potential risk factor for the development of endometrial cancer. However, the molecular mechanisms underlying the …
The immunotherapy era in ovarian clear cell carcinoma: current evidence and future perspective.
Ovarian clear cell carcinoma (OCCC) is a rare, aggressive epithelial ovarian cancer subtype, accounting for approximately 10% of cases and associated with a poor prognosis due to chemoresistance and unique …
A Risk-Stratified Model for Predicting Endometrial Atypical Hyperplasia and Cancer to Guide Biopsy Decisions in Asymptomatic Postmenopausal Women - Frontiers
A Risk-Stratified Model for Predicting Endometrial Atypical Hyperplasia and Cancer to Guide Biopsy Decisions in Asymptomatic Postmenopausal Women Frontiers
Mesonephric-like Adenocarcinoma (MLA) Diagnostic Criteria and Controversies: Perspectives and Guidance From Pathologists in the MLA Consortium.
Mesonephric-like adenocarcinoma (MLA) is a rare and aggressive gynecologic malignancy that has only been recognized in the last decade. It arises in the endometrium, ovaries, and other extrauterine sites (often …
Massive serous cystadenofibroma with incidental umbilical endometriosis in a morbidly obese patient presenting as acute respiratory compromise.
We present a case of a woman in her 50s with a rapidly expanding giant serous cystadenofibroma of the ovary. The 40-kg mass displaced her bowel and splinted her diaphragm, …